GKWIM
REGN icon

Gerber Kawasaki Wealth & Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,561
Closed -$1.64M – 299
2024
Q3 		$1.64M Buy
1,561
+330
+27% +$367K 0.08% 112
2024
Q2 		$1.29M Buy
1,231
+559
+83% +$542K 0.06% 120
2024
Q1 		$647K Buy
+672
New +$639K 0.03% 155

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's REGN Position: Q4 2024 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 1,561 shares — an estimated $1.64M sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in REGN in Q1 2024 and held it in 3 quarters. The position peaked at $1.64M in Q3 2024. 1,318 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 1,561 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $1.64M.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Regeneron Pharmaceuticals position peaked at $1.64M in Q3 2024.
  • 1,318 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.